abstract |
The present invention also embraces compounds of formula (I) or (II) as defined herein, as well as compounds and pharmaceutical compositions for the treatment of medical disorders such as immunological inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis and allergy ≪ / RTI > The compounds are believed to modulate T-cell responses. (I) ≪ |